Related Experiment Video

Updated: Jan 9, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

493

Targeting piroplasmosis and theileriosis: New frontiers in drug development

Ritika Rajput1,2, Amar Prajapati1,2, Anand Srivastava3,4

  • 1Biotechnology Research Innovation Council-National Institute of Animal Biotechnology (BRIC-NIAB), Gachibowli, Gopanpalli, Hyderabad, Telangana, 500032, India.

Tropical Animal Health and Production
|December 9, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
BabesiosisChemotherapeuticControl strategiesDrug targetsDrugsPiroplasmosisTheileriosis

More Related Videos

Generating Genetically Modified Plasmodium berghei Sporozoites10:16

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

1.7K
In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

3.7K

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K